Charlson Mary E, Wells Martin T, Hollenberg James, Ramos Rosio, Martinez Guillerma Maritza, Gerard Martin J, Cassells Andrea, Lin T J, Mittleman Ilana, Eggleston Alice, Tobin Jonathan N
Weill Cornell Medicine, Department of Medicine, New York, NY, USA.
Cornell University, Ithaca, NY, USA.
J Clin Transl Sci. 2024 Nov 6;8(1):e191. doi: 10.1017/cts.2024.598. eCollection 2024.
Social determinants of health (SDOH) are an important contributor to health status and health outcomes. In this analysis, we compare SDOH measured both at the individual and population levels in patients with high comorbidity who receive primary care at Federally Qualified Health Centers in New York and Chicago and enrolled in the Tipping Points trial.
We analyzed individual- and population-level measures of SDOH in 1,488 patients with high comorbidity (Charlson Comorbidity Index ≥ 4) enrolled in Tipping Points. At the individual level, we used a standardized patient-reported questionnaire. At the population level, we employed patient addresses to calculate the Social Deprivation Index (SDI) and Area Deprivation Index. Multivariable regressions were conducted in addition to qualitative feedback from stakeholders.
Individual-level SDOH are distinct from population-level measures. Significant component predictors of population SDI are being unhoused, unable to pay for utilities, and difficulty accessing medical transportation. Qualitative findings mirrored these results. High comorbidity patients report significant SDOH challenges at the individual level. Fitting a binomial generalized linear model, the comorbidity score is significantly predicted by the composite individual SDOH index ( < 0.0001) controlling for age and race/ethnicity.
Individual- and population-level SDOH measures provide different risk assessments. The use of community-level SDI data is informative in the aggregate but should not be used to identify patients with individual unmet social needs. Health systems should implement a standardized individualized assessment of unmet SDOH needs and build strong, enduring partnerships with community-based organizations that can provide those services.
健康的社会决定因素(SDOH)是健康状况和健康结果的重要影响因素。在本分析中,我们比较了纽约和芝加哥联邦合格健康中心接受初级保健并参加“转折点”试验的高合并症患者在个体和人群层面所测量的SDOH。
我们分析了参加“转折点”试验的1488例高合并症患者(查尔森合并症指数≥4)的个体和人群层面的SDOH指标。在个体层面,我们使用了标准化的患者报告问卷。在人群层面,我们利用患者地址计算社会剥夺指数(SDI)和地区剥夺指数。除了利益相关者的定性反馈外,还进行了多变量回归分析。
个体层面的SDOH与人群层面的指标不同。人群SDI的重要组成预测因素包括无家可归、无力支付水电费以及难以获得医疗运输服务。定性研究结果与这些结果相符。高合并症患者在个体层面报告了重大的SDOH挑战。通过拟合二项式广义线性模型,在控制年龄和种族/族裔的情况下,合并症评分由个体SDOH综合指数显著预测(<0.0001)。
个体和人群层面的SDOH测量提供了不同的风险评估。社区层面的SDI数据总体上具有参考价值,但不应将其用于识别有未满足的个体社会需求的患者。卫生系统应实施标准化的个体化评估,以确定未满足的SDOH需求,并与能够提供这些服务的社区组织建立牢固、持久的伙伴关系。